Skip to Main Content

Paper Details

Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer.
Nat Cancer
36
2023
Author NameAffiliation
Anirban MaitraThe University of Texas MD Anderson Cancer Center
Yaoqi Alan WangThe University of Texas MD Anderson Cancer Center
Yaoqi Alan WangBrown Center for Immunotherapy, Indiana University School of Medicine
Yaoqi Alan WangIndiana University School of Medicine
Yaoqi Alan WangIndiana University School of Medicine
Yaoqi Alan WangIndiana University Melvin and Bren Simon Comprehensive Cancer Center
  • 1 - 6

Datasets

Release 1.2